S J Meischen
Overview
Explore the profile of S J Meischen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
28
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
GALE G, Atkins L, Meischen S, Schwartz P
Cancer Treat Rep
. 1979 Mar;
63(3):449-56.
PMID: 427825
Each of three ribonucleoside diphosphate reductase inhibitors was used as a third drug in combination with selected antitumor platinum (Pt) agents and cyclophosphamide (CY) in the treatment of advanced L1210...
2.
GALE G, Atkins L, Meischen S, Schwartz P
Cancer
. 1978 Apr;
41(4):1230-4.
PMID: 638988
Seven new organoplatinum (Pt) compounds, cyclophosphamide (CY), and hydroxyurea (HU) were used singly and in combination in treatment of advanced L1210 leukemia in C57BL/6 X DBA/2 mice. In each experiment...
3.
GALE G, Atkins L, Schwartz P, Meischen S
Bioinorg Chem
. 1978 Jan;
8(5):445-51.
PMID: 687671
Nine new organoplatinum (Pt) compounds, cyclophosphamide (CY), and 5-fluorouracil (FU) were used singly and in combination in treatment of advanced L1210 leukemia in C57BL/6 X DBA/2 hybrid mice. In each...
4.
Schwartz P, Meischen S, GALE G, Atkins L, Smith A, Walker Jr E
Cancer Treat Rep
. 1977 Nov;
61(8):1519-25.
PMID: 922755
The structure of the antitumor agent, dichloro(1,2-diaminocyclohexane)platinum(II) (NSC-194814), was modified by replacing the chlorides with organic or inorganic anions. Eighteen new platinum complexes were so isolated and their antitumor properties...
5.
GALE G, Atkins L, Meischen S, Smith A, Walker Jr E
Cancer Treat Rep
. 1977 May;
61(3):445-50.
PMID: 872142
Six antitumor platinum compounds were used in combination with cyclophosphamide (CY) plus one of five other antitumor drugs in the treatment of advanced (Day 3) L1210 leukemia in (C57BL/6 X...
6.
Glae G, Atkins L, Meischen S, Smith A, Walker Jr E
J Natl Cancer Inst
. 1976 Dec;
57(6):1363-6.
PMID: 187805
Six antitumor platinum compounds were used in combination with cyclophosphamide plut 1 of 7 other antitumor drugs for treatment of L1210 leukemia in B6D2F [C57BL/6 X DMA/2) F] mice. Data...
7.
Meischen S, GALE G, Lake L, Frangakis C, Rosenblum M, Walker Jr E, et al.
J Natl Cancer Inst
. 1976 Oct;
57(4):841-5.
PMID: 1003531
The antitumor activity of 46 cis-amineplatinum congeners was evaluated against L1210 leukemia in (C57BL/L X DBA/2)F1 mice. Several compounds in this series significantly prolonged the life-spans of mice with the...
8.
Ogawa M, GALE G, Meischen S, Cooke V
Cancer Res
. 1976 Sep;
36(9 pt.1):3185-8.
PMID: 975083
We studied the effects of dinitrato (1,2,-diaminocyclohexane)platinum (NSC 239851) on murine myeloma Adj. PC-5 and hemopoietic precursor cells. The median survival time of tumor-bearing mice was significantly affected by i.p....
9.
GALE G, Walker Jr E, Atkins L, Smith A, Meischen S
Res Commun Chem Pathol Pharmacol
. 1974 Mar;
7(3):529-38.
PMID: 4824827
No abstract available.
10.
GALE G, Rosenblum M, Atkins L, Walker Jr E, Smith A, Meischen S
J Natl Cancer Inst
. 1973 Oct;
51(4):1227-34.
PMID: 4583374
No abstract available.